The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion offer.

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ...

Japan: A study published in the Journal of Refractive Surgery reports that horizontal fixation of implantable collamer lenses ...

Oct. 10, 2023 10:51 AM ETSTAAR Surgical Company (STAA) STAAR Surgical is equally enthusiastic about this collaboration. Tom Frinzi, CEO of STAAR Surgical, states, "We are happy to have Jimmy O. Yang ...

“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch – achieving market leadership ...

Clear, sharp vision is a game-changer, and for those seeking an alternative to LASIK, Implantable Collamer Lens or ICL surgery offers an innovative solution. Unlike laser-based procedures, ICL ...

(RTTNews) - STAAR Surgical Company (STAA) Tuesday announced partnership with ophthalmology group, SharpeVision to provide EVO ICL lenses to all qualified patients in SharpeVision clinics. STAAR ...

Prestigious three-year multicenter clinical trial confirms revolutionary implantable lens technology achieves exceptional visual outcomes with minimal complications Dr. Jason P. Brinton of Brinton ...

Carrot LASIK & Eye Center is shedding light on one of the most important but often overlooked aspects of refractive surgery—the material used in the implantable lens itself. In its latest article, EVO ...